Cargando…
Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
BACKGROUND: Breast cancer is one of the most common malignancies threatening women’s health. Triple-negative breast cancer (TNBC) is a special type of breast cancer with high invasion and metastasis. CXCL12 and its receptors CXCR4 and CXCR7 play a crucial role in the progress of breast cancer. The a...
Autores principales: | Yang, Meng, Zeng, Chen, Li, Peiting, Qian, Liyuan, Ding, Boni, Huang, Lihua, Li, Gang, Jiang, Han, Gong, Ni, Wu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527053/ https://www.ncbi.nlm.nih.gov/pubmed/31190884 http://dx.doi.org/10.2147/OTT.S195661 |
Ejemplares similares
-
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
por: Hou, Panpan, et al.
Publicado: (2015) -
CRISPR/Cas9‑mediated EZH2 knockout suppresses the proliferation and migration of triple‑negative breast cancer cells
por: Mao, Qiqi, et al.
Publicado: (2023) -
HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
por: Liu, Shuai, et al.
Publicado: (2018) -
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2014) -
CXCR7 Controls Competition for Recruitment of β-Arrestin 2 in Cells Expressing Both CXCR4 and CXCR7
por: Coggins, Nathaniel L., et al.
Publicado: (2014)